Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Bicalutamide for NAFLD and PCOS
Recruiting0 awardsPhase 1
San Francisco, California
This trial will study the risk of NASH in women, looking at androgen hormones and lipid metabolism. It may provide insight to help protect the 15 million US women with NASH from early onset liver disease. #NASH #women #liverdisease
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.